Please login to the form below

China biotech

This page shows the latest China biotech news and features for those working in and with pharma, biotech and healthcare.

Moderna and GSK advance coronavirus vaccine candidates

Biotech company Moderna announced yesterday that its has released the first batch of its vaccine – mRNA-1273 – for human use. ... The company has partnered with China-based biotech company Clover Biopharmaceuticals on its protein-based coronavirus

Latest news

Chi-Med cues up two more regulatory filings in cancer

in the China National Reimbursement Drug List (NRDL) at the next update later this year. ... NET) it is on course to file for approval in China before year-end.
Swedish biotech Calliditas signs China licensing deal for autoimmune candidate

The Swedish biotech launched its initial public offering (IPO) on the Stockholm Nasdaq last year, and has now secured a valuable partner which could unlock access to China's huge market. ... China is the world's largest market in terms of the number of
Gracell Bio developing faster, cheaper CAR-T production

Manufacturing can be cut from two weeks to one day. Gracell Bio has launched its new CAR-T production platform, and the China-based biotech claims its technology can reduce the
Chi-Med goes for third IPO in Hong Kong

The current pace of development of the biotech ecosystem in China is remarkable,” said Simon To, Chi-Med’s chairman. ... It is being fuelled by the major unmet medical needs in China, systemic regulatory reforms that are accelerating new drug
Roivant forms Asian cell therapy ‘vant’, with Medigene’s help

The new biotech – called Cytovant – is being set up by Roivant in conjunction with its recently-formed Chinese subsidiary Sinovant, and starts life with a pipeline based on two programmes licensed ... The new biotech will be headed by former

More from news
Approximately 5 fully matching, plus 17 partially matching documents found.

Latest Intelligence

China’s homecoming heroes fuel a biotech boom with rapid CAR-T advances

The nation’s biotech boom is rocking the laboratories and trading floors of the world as China secures a place at the forefront of innovative medicine, casting off its reputation as ... At the spear point is China’s emergence as the epicentre of
Deal Watch October 2016

150. AstraZeneca (UK). 3SBio. Distribution. Byetta, Bydureon (exanatide) for Type 2 diabetes in China. ... 100. Active Biotech (SE). NeoTx (IS). Licence. Tumour Targeting Superantigen ANYARA in phase I for oncology.
Russian innovation at the crossroads

The company is expected to launch its products in the US and China. ... Russia's biotech sector has high untapped potential. Rising risks but solid foundations.

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

Silence Therapeutics adds to leadership team

Prior to this, he held the same title at RiboBio, an oligonucleotide-focused biotech based in China, between 2011 and 2015, and served as vice president of technology development at RXi

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company

Porterhouse Medical Group

The Porterhouse Medical Group provides powerful, insight-driven, scientific and medical communication services to the pharmaceutical industry across the globe, with...

Latest intelligence

InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping: Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much: Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
7 important considerations for creating an inclusive clinical trial website: You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...